PROTECT-APT 1 Study

I'm Interested!

Early Treatment and Post-Exposure Prophylaxis of COVID-19 - Adaptive Platform Trial (PROTECT-APT 1)

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase I
Conditions Being Studied: COVID-19

Study Purpose

The purpose of this research study is to test the ability of an investigational study drug to shorten and reduce a COVID-19 infection. In addition, researchers will study how well the study drug works against the virus that causes COVID-19 and continue to monitor the safety of the study drug.

Who Can Participate

Participants 18 years and older diagnosed with COVID be eligible for this study.

Principal Investigator
Grace McComsey MD

Department/Division
Medicine (Infectious Disease)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: SITE00002196
StudyID: 2024-01447
ClinicalTrials.gov: N/A

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422